Corticosteroid-related central nervous system side effects
- 1,
- 2,
- 3,
- 3,
- 3,
- 3,
- 3*
- 1Department of Science of Health, School of Medicine, University of Catanzaro and Pharmacovigilance’s Centre Calabria Region, University Hospital Mater Domini, Catanzaro, Italy.
- 2Geriatry Unit, General Hospital Pugliese-Ciaccio, Catanzaro, Italy.
- 3Presidio Ospedaliero Unico, Soverato, Catanzaro, Italy.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Emilio Russo
Presidio Ospedaliero Unico, Soverato, Catanzaro, Italy.
Email: erusso@unicz.it
Copyright: © 2013 The Author(s). This is an open access article.
Abstract
Corticosteroids have been used since the 50s as anti-inflammatory and immunosuppressive drugs for the treatment of several pathologies such as asthma, allergy, rheumatoid arthritis, and dermatological disorders. Corticosteroids have three principal mechanisms of action: 1) inhibit the synthesis of inflammatory proteins blocking NF-kB, 2) induce the expression of anti-inflammatory proteins by IkB and MAPK phosphatase I, and 3) inhibit 5-lipoxygenase and cyclooxygenase-2. The efficacy of glucocorticoids in alleviating inflammatory disorders results from the pleiotropic effects of the glucocorticoid receptors on multiple signaling pathways. However, they have adverse effects: Growth retardation in children, immunosuppression, hypertension, hyperglycemia, inhibition of wound repair, osteoporosis, metabolic disturbances, glaucoma, and cataracts. Less is known about psychiatric or side effects on central nervous system, as catatonia, decreased concentration, agitation, insomnia, and abnormal behaviors, which are also often underestimated in clinical practice. The aim of this review is to highlight the correlation between the administration of corticosteroids and CNS adverse effects, giving a useful guide for prescribers including a more careful assessment of risk factors and encourage the use of safer doses of this class of drugs.
Keywords
Subject
Recommended articles
- Adverse Drug Reactions to Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis
Smrati Tiwari, Zahaan Vakil · Journal of Pharmacology and Pharmacotherapeutics
- Nexavar®-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012
Felisa Cilurzo, Orietta Staltari, Marinella Patanè · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026